In a 48-year-old woman with systemic lupus erythematosus on 25 mg prednisone daily and hydroxychloroquine who presents with hypoxia and cough, with chest X‑ray showing bilateral opacities without effusion and a CT chest ordered, what are the next management steps?

Management of Suspected Lupus Pneumonitis in a Patient with SLE

This patient requires immediate aggressive workup for infection followed by high-dose corticosteroid therapy if infectious causes are excluded, as bilateral pulmonary opacities with hypoxia in an immunosuppressed lupus patient represents a medical emergency with high mortality risk.

Immediate Diagnostic Workup

The CT chest already ordered is essential, but you must simultaneously pursue an urgent infectious workup before escalating immunosuppression:

Critical Infectious Evaluation

• Obtain immediately: Blood cultures, sputum culture and sensitivity, nasal swab for respiratory viruses (including COVID-19), urine culture
• Consider bronchoscopy with bronchoalveolar lavage (BAL) if patient can tolerate—this is particularly important in grade 2 or higher severity to rule out infection before intensifying immunosuppression 1
• Pulse oximetry monitoring and assess oxygen requirements 1

Additional Laboratory Assessment

• Complete blood count (assess for anemia suggesting possible diffuse alveolar hemorrhage)
• Anti-dsDNA and complement levels (C3, C4) to assess lupus activity
• Consider diffusing capacity (DLCO) if baseline available—may be elevated in diffuse alveolar hemorrhage 1

Severity Grading and Treatment Algorithm

Grade 2 (Symptomatic with hypoxia, bilateral involvement, limiting instrumental activities of daily living):

• Hold any additional immunosuppressants temporarily until infection ruled out
• Continue hydroxychloroquine at current dose 2, 3
• Initiate prednisone 1-2 mg/kg/day (approximately 50-100 mg daily for a 48-year-old woman) once infection reasonably excluded 1
• Consider empiric antibiotics if infection remains in differential after initial workup 1
• Monitor at least weekly with history, physical examination, pulse oximetry, and consider repeat imaging 1
• Pulmonary and infectious disease consultations 1

If no clinical improvement after 48-72 hours of prednisone, escalate to Grade 3 management 1

Grade 3 or 4 (Severe symptoms, oxygen required, or life-threatening):

• Hospitalize immediately
• Methylprednisolone IV 1-2 mg/kg/day (approximately 50-100 mg IV daily) 1
• If no improvement after 48 hours, add second-line immunosuppressive agent: infliximab, mycophenolate mofetil IV, IVIG, or cyclophosphamide 1
• Taper corticosteroids over 4-6 weeks once improvement occurs 1

Special Consideration: Diffuse Alveolar Hemorrhage

If hemoptysis develops or hemoglobin drops significantly (mean drop 3.2 g/dL in lupus-associated pulmonary hemorrhage), this represents diffuse alveolar hemorrhage—a life-threatening complication requiring:

• High-dose methylprednisolone pulses (typically 500-1000 mg IV daily for 3 days) 4, 5
• Pulse cyclophosphamide 4, 6, 5
• Consider plasmapheresis for acutely ill patients not responding to above measures 6, 5
• ICU-level care with potential need for intubation or ECMO in severe cases 6
• Mortality rate approaches 36% even with aggressive treatment 5

Critical Pitfalls to Avoid

1. Do not increase oral prednisone dose without ruling out infection first—this patient is already on 25 mg daily, making her susceptible to opportunistic infections
2. Do not assume this is lupus pneumonitis without excluding infection—the bilateral opacities could represent pneumonia, particularly given her immunosuppressed state
3. Do not delay bronchoscopy in grade 2 or higher disease—BAL is critical for excluding infection and may show hemorrhagic return if DAH present 1
4. Consider PCP prophylaxis if corticosteroid dose will exceed 20 mg methylprednisolone equivalent for ≥4 weeks 7
5. Start proton pump inhibitor for GI prophylaxis with high-dose steroids 7

Maintenance Considerations

Once acute episode controlled:

• Taper steroids slowly over 4-6 weeks minimum 1
• Continue hydroxychloroquine at 5 mg/kg/day (approximately 200-400 mg daily for most patients) 8, 9, 10
• Consider adding or optimizing immunosuppressive therapy (mycophenolate, azathioprine, or belimumab) to facilitate steroid taper and prevent recurrence 9
• Some patients develop chronic pneumonitis requiring longer steroid tapers (<2% incidence) 1

The key is aggressive early intervention while simultaneously excluding infection—delay in treatment of lupus pneumonitis or DAH significantly increases mortality, but inappropriate immunosuppression in the setting of infection is equally dangerous.